The global equine healthcare market size is expected to reach USD 6.65 billion by 2032, exhibiting a CAGR of 8.1% during 2024–2032.
Equine healthcare is essential for ensuring the longevity and performance of horses, whether for racing, sports, leisure, or agricultural purposes. The market includes various preventative and curative healthcare products and services that address issues like infectious diseases, parasitic infestations, and musculoskeletal injuries. Additionally, nutritional management and regular health monitoring are vital aspects of equine care.
Market Growth Drivers
- Rising Prevalence of Equine Diseases Diseases such as equine influenza, equine herpesvirus (EHV), and colic are common among horses, necessitating regular vaccinations, deworming, and other healthcare measures. The need for disease prevention and treatment is a significant driver of the market.
- Growing Popularity of Equestrian Sports The increasing prominence of equestrian sports globally, including events in the Olympics and regional competitions, has led to higher demand for advanced healthcare products and services to maintain the performance and well-being of horses.
- Increasing Horse Ownership for Recreation The adoption of horses for recreational activities and therapeutic purposes is on the rise, particularly in developed regions. This trend supports the growth of healthcare services tailored for non-sporting horses.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/equine-healthcare-market/request-for-sample
List of Key Companies in Equine Healthcare Market
- Zoetis Services LLC
- Boehringer Ingelheim International GmbH
- Arthrex Inc.
- Dechra
- Ceva Sante Animale
- Merck & Co., Inc.
- Heska Corporation
- Hallmarq Veterinary Imaging
Key Trends
- Integration of Technology in Equine Healthcare The adoption of wearable devices and telemedicine solutions for remote monitoring of equine health is a rising trend. These technologies help track vital signs, detect early signs of illness, and improve overall care.
- Personalized Nutrition Plans Customized dietary supplements tailored to meet the specific needs of individual horses are gaining popularity. This trend is driven by a focus on improving performance and managing chronic conditions.
- Regenerative Medicine in Equine Treatment Regenerative therapies, such as platelet-rich plasma (PRP) and stem cell treatments, are being increasingly used for treating musculoskeletal injuries, offering faster recovery and improved outcomes.
𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
The research study includes segmental analysis that divides the market into distinct groups or segments based on common characteristics. With market segmentation, businesses can identify specific customer groups that are more likely to be interested in specific products or services. Also, it enables these businesses to focus their marketing efforts and resources more efficiently, leading to higher conversion rates and improved return on investment. Furthermore, segmentation analysis helps companies develop personalized products or services, which can result in increased customer loyalty and improved customer satisfaction.
By Product Outlook (Revenue, USD Billion, 2019–2032)
- Vaccines
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory & Analgesics
- Other Pharmaceuticals
- Medicinal Feed Additives
- Orthobiologics
- Diagnostics
- Diagnostic Test Kits
- Diagnostic Equipment
- Software
- Practice Management Software
- Imaging Software
- Telehealth Software
- Other Software
- Other
By Indication Outlook (Revenue, USD Billion, 2019–2032)
- Musculoskeletal Disorders
- Parasitic Infections
- Equine Herpes Virus
- Equine Viral Arteritis (EVA)
- Equine Influenza
- West Nile Virus
- Tetanus
- Other
By Activity Outlook (Revenue, USD Billion, 2019–2032)
- Sports/Racing
- Recreation
- Other
By Distribution Channel Outlook (Revenue, USD Billion, 2019–2032)
- Veterinary Hospitals & Clinics
- E-commerce
- Equestrian Facilities
- Other
Recent Developments in Industry
- In November 2021, Biosig Instruments Inc., a global player in heart rate technology since 1975, launched the Insta-Pulse Equine heart rate monitor, the model 109. The company claims that this unique device delivers ease of use, continuous monitoring of the heart of the horse, and automatic start.
- In September 2021, Dechra announced the acquisition of the veterinary marketing and distribution firm Hassinger Biomedical to enhance its product portfolio for equine healthcare significantly.
The Equine Healthcare Market is set for sustained growth, fueled by advancements in veterinary medicine, the increasing popularity of equestrian sports, and rising awareness about horse welfare. While challenges like high costs and limited veterinary expertise persist, ongoing innovations in diagnostics, treatment, and preventative care are poised to address these issues.